Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 2972

    Article Cited by others

REVIEW ARTICLE

Evolution and etiopathogenesis of bisphosphonates induced osteonecrosis of the jaw

Kumar Vijay, Sinha Raman Kant

Year : 2013| Volume: 5| Issue : 4 | Page no: 260-265

   This article has been cited by
 
1 Medication-related osteonecrosis of the jaw in a minipig model: parameters for developing a macroscopic, radiological, and microscopic grading scheme
Nowicki B,Nehrbass D,Arens D,Stadelmann VA,Zeiter S,Otto S,Kircher P,Stoddart MJ
Journal of Cranio-Maxillofacial Surgery. 2019;
[Pubmed]  [Google Scholar] [DOI]
2 Histologic analysis of medication-related osteonecrosis of the jaw compared to antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases
Anna Yuan,Adelheid Munz,Siegmar Reinert,Sebastian Hoefert
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2019;
[Pubmed]  [Google Scholar] [DOI]
3 Resection and microvascular reconstruction of bisphosphonate-related osteonecrosis of the jaw: The role of microvascular reconstruction
Tiago Neto,Ricardo Horta,Rui Balhau,Lígia Coelho,Pedro Silva,Inês Correia-Sá,Álvaro Silva,David W. Eisele
Head & Neck. 2016;
[Pubmed]  [Google Scholar] [DOI]
4 Comparison of acute side effect profile of zoledronic acid – Innovator versus generic preparation
Gunjan Garg,Atul Gogia,Atul Kakar
Current Medicine Research and Practice. 2016; 6(5): 181
[Pubmed]  [Google Scholar] [DOI]
5 Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases
Sebastian Hoefert,Inge Schmitz,Frank Weichert,Marcel Gaspar,Harald Eufinger
Clinical Oral Investigations. 2015; 19(2): 497
[Pubmed]  [Google Scholar] [DOI]
6 The inhibition of RANK-ligand in the management of postmenopausal osteoporosis and related fractures: the role of denosumab
Anna Capozzi,Stefano Lello,Alfredo Pontecorvi
Gynecological Endocrinology. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
7 Zoledronate but not denosumab suppresses macrophagic differentiation of THP-1 cells. An aetiologic model of bisphosphonate-related osteonecrosis of the jaw (BRONJ)
Sebastian Hoefert,Claudia Sade Hoefert,Marc Albert,Adelheid Munz,Martin Grimm,Hinnak Northoff,Siegmar Reinert,Dorothea Alexander
Clinical Oral Investigations. 2014;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article